mail
editor@ajptr.com
whatsapp
9409046853
logo

American Journal of PharmTech Research

YK. Agrawal

Author Profile
Institute of Research and Development, Gujarat Forensic Sciences University, Gandhinagar-382007, Gujarat, India.
1
Publications
1
Years Active
2
Collaborators
50
Citations

Publications by YK. Agrawal

1 publication found • Active 2013-2013

2013

1 publication

Avanafil: A Novel Agent for Management of Erectile Dysfunction, Its Clinical And Analytical Approach

with Jasmin Kubawat, Unnati S. Patel
6/1/2013

Erectile dysfunction is the sexual dysfunction characterized by inability to maintain an erection of penis during sexual performance. Oral phosphodiesterase type 5 inhibitors drugs are successful for treatment of impotence such as sildenafil, vardenafil, tadalafil, alprostadil and avanafil. Clinical trials reveals that avanafil have faster onset of action as well as higher specificity for phosphodiesterase type 5 inhibitors with fewer side effects in comparision of other oral phosphodiesterase type 5 inhibitors drugs. In case of analytical method only LC-MS/MS method has been done. There may be chances of analytical study of avanafil will be done in future by using various spectroscopy method.

Author Statistics
Total Publications:1
Years Active:1
First Publication:2013
Latest Publication:2013
Collaborators:2
Citations:50
Whatsapp